XCS6:XETRA:XETRA-Xtrackers MSCI China UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 14.722

Change

+0.21 (+1.48)%

Market Cap

USD 1.17B

Volume

0.16M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.06 (-0.11%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.15%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.11%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.11%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-0.12 (-0.08%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

-0.05 (-0.10%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.11 (-0.22%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.27 (-0.28%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.66 (-0.12%)

USD 80.38B

ETFs Containing XCS6:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 26.28% 95% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.28% 95% A 92% A
Trailing 12 Months  
Capital Gain 15.47% 48% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.47% 48% F 51% F
Trailing 5 Years  
Capital Gain -0.98% 26% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.98% 25% F 30% F
Average Annual (5 Year Horizon)  
Capital Gain -6.13% N/A N/A 10% F
Dividend Return -6.13% N/A N/A 10% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 18.50% N/A N/A 35% F
Risk Adjusted Return -33.15% N/A N/A 18% F
Market Capitalization 1.17B 80% B- 71% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike